Login

Switch On Your HIV Smarts.

NEXT-PrEP: A New Study of Maraviroc for HIV Prevention

NEXT-PrEP: A New Study of Maraviroc for HIV Prevention

July 19, 2012, by

Learn more about the NEXT-PrEP study—the first to test the antiretroviral drug maraviroc as a once-daily HIV-prevention pill. Read More

Good News from HPV Vaccination Study

Good News from HPV Vaccination Study

July 17, 2012, by

New research suggests vaccination against a cancer-causing virus is helping to lower infection rates—even for women who aren't vaccinated. Read More

FDA Approves Truvada for PrEP

FDA Approves Truvada for PrEP

July 16, 2012, by

See why this new HIV prevention tool is both essential and controversial—and why there's still work to do around PrEP. Read More

Ask a Lawyer: The Affordable Care Act Survives—What Now?

Ask a Lawyer: The Affordable Care Act Survives—What Now?

July 16, 2012, by

Law professor Ari Ezra Waldman dissects the Supreme Court's decision on the Affordable Care Act, and what it means for people with HIV. Read More

Dolutegravir Looks Good in Another Advanced Clinical Trial

Dolutegravir Looks Good in Another Advanced Clinical Trial

July 13, 2012, by

Learn more about this next-generation integrase inhibitor and see how it stacks up against popular HIV drug regimen Atripla. Read More